Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Supplementary Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
Home
Publications
Supplementary Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
Supplementary Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
Authors:
BH
Beiyuan Hu
Beiyuan Hu
TZ
Tiantian Zou
Tiantian Zou
WQ
Wei Qin
Wei Qin
XS
Xiaotian Shen
Xiaotian Shen
YS
Yinghan Su
Yinghan Su
JL
Jianhua Li
Jianhua Li
YC
Yang Chen
Yang Chen
ZZ
Ze Zhang
Ze Zhang
HS
Haoting Sun
Haoting Sun
YZ
Yan Zheng
Yan Zheng
CW
Chao-Qun Wang
Chao-Qun Wang
ZW
Zhengxin Wang
Zhengxin Wang
See more
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Open Access
Publisher website
Google Scholar
31 March 2023
other
Published by
American Association for Cancer Research (AACR)
DOI:
10.1158/0008-5472.22432256
Abstract
Supplementary Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
Keywords
CARCINOMA SUPPLEMENTARY
DATA FROM INHIBITION
EGFR OVERCOMES ACQUIRED
INHIBITION OF EGFR
SUPPLEMENTARY DATA
LENVATINIB
STAT3
Related articles
Scroll to top